✦ LIBER ✦

SUSTAINED LEVODOPA THERAPY IN PARKINSONISM

✍ Scribed by HUNTER, K

Book ID: 122784247
Publisher: The Lancet
Year: 1973
Tongue: English
Weight: 414 KB
Volume: 302
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(73)92595-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of sustained deprenyl (selegiline

Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: A randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial

✍ Ira Shoulson; David Oakes; Stanley Fahn; Anthony Lang; J. William Langston; Pete 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 3 views

SUSTAINED-RELEASE LEVODOPA IN PARKINSONI

SUSTAINED-RELEASE LEVODOPA IN PARKINSONISM

✍ Curzon, G; Friedel, June; Grier, Linda; Marsden, C.D; Parkes, J.D; Shipley, M; Z 📂 Article 📅 1973 🏛 The Lancet 🌐 English ⚖ 147 KB

SUSTAINED-RELEASE LEVODOPA IN PARKINSONI

SUSTAINED-RELEASE LEVODOPA IN PARKINSONISM

✍ Eckstein, Beatrice; Shaw, Kenneth; Stern, Gerald 📂 Article 📅 1973 🏛 The Lancet 🌐 English ⚖ 363 KB

LEVODOPA AND L-TRYPTOPHAN THERAPY IN PAR

LEVODOPA AND L-TRYPTOPHAN THERAPY IN PARKINSONISM

✍ Coppen, Alec; Metcalfe, Maryse; Carroll, J.D.; Morris, J.G.L. 📂 Article 📅 1972 🏛 The Lancet 🌐 English ⚖ 715 KB

Parkinson's disease/Parkinson syndromes—

Parkinson's disease/Parkinson syndromes—therapy: Levodopa

📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB

Three patients with Parlcinson's disease, optimally treated with levodopdcabidopa (LDKD) tablets, but experiencing severe motor fluctuations, were administered a solution of levodopd carbidopalascorbic acid (LCAS) orally at intervals ranging from 30 to 60 minutes. Patients were rated half-hourly to

LEVODOPA IN POSTENCEPHALITIC PARKINSONIS

LEVODOPA IN POSTENCEPHALITIC PARKINSONISM

✍ Hunter, K.R; Stern, G.M; Sharkey, J 📂 Article 📅 1970 🏛 The Lancet 🌐 English ⚖ 325 KB